Polymyalgia rheumatica other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Polymyalgia Rheumatica Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Polymyalgia rheumatica from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Polymyalgia rheumatica other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Polymyalgia rheumatica other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Polymyalgia rheumatica other diagnostic studies
CDC on Polymyalgia rheumatica other diagnostic studies
Polymyalgia rheumatica other diagnostic studies in the news
Blogs on Polymyalgia rheumatica other diagnostic studies
Directions to Hospitals Treating Polymyalgia rheumatica
Risk calculators and risk factors for Polymyalgia rheumatica other diagnostic studies

Overview

A muscle biopsy might be performed to differentiate polymyalgia rheumatica (PMR) from other diseases. In addition, temporal artery biopsy is required when a subject with PMR have symptoms suggestive of giant cell arteritis.

Other Diagnostic Studies

Muscle biopsy

• It might be performed to differentiate polymyalgia rheumatica (PMR) from other myopathies.

Temporal artery biopsy

• It may be helpful when there are signs and symptoms of giant cell arteritis.

• Patients with PMR should be monitored regularly after treatment with glucocorticoids as PMR may progress to giant cell arteritis.